Lung cancer study aims to fill gaps left by clinical trials

This study is collecting blood and tumor samples from 730 newly diagnosed lung cancer patients at Nantes University Hospital. Researchers will follow patients from diagnosis until death to understand how treatments work in real life, especially for patients often left out of clinical trials. The goal is to build a resource for future research on treatment resistance and outcomes.